Study guide

13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

Key Takeaways Explain This Topic AI

Erythema migrans is an expanding red patch of at least 5 cm appearing days to weeks after an Ixodes tick bite, and it is diagnosed clinically without serology.

European guidelines treat erythema migrans with doxycycline for about 10 to 14 days, or amoxicillin in children and pregnancy, and treat acrodermatitis chronica atrophicans for about 21 to 28 days.

Acrodermatitis chronica atrophicans is a late Lyme manifestation, usually caused by Borrelia afzelii, with violaceous then atrophic skin on the extensor limbs of older adults and high IgG antibody titres.

Mediterranean spotted fever, caused by Rickettsia conorii, presents with fever, a black eschar (tache noire) at the tick bite site, and a maculopapular rash including the palms and soles.

Cutaneous larva migrans, caused by animal hookworm larvae after walking barefoot on beaches, produces itchy serpiginous tracks and is treated with oral ivermectin or albendazole.

Last updated: September 2026

  • 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
  • Lyme Borreliosis

Lyme borreliosis is the most common tick-borne infection in Europe. It is caused by spirochaetes of the Borrelia burgdorferi sensu lato complex and transmitted by Ixodes ricinus ticks. The risk of transmission rises with the time the tick is attached.

  • Species Typical Clinical Picture in Europe
  • B. afzelii Skin: erythema migrans, acrodermatitis chronica atrophicans , borrelial lymphocytoma
  • B. garinii Neuroborreliosis
  • B. burgdorferi sensu stricto Arthritis (the main species in North America)
  • Clinical Stages

Stage Manifestations

Early localised (days to weeks) Erythema migrans (EM): an expanding red patch at least 5 cm across, appearing about 3–30 days after the bite, often with central clearing. Borrelial lymphocytoma: a painless blue-red nodule on the earlobe (children) or nipple and areola (adults)

Early disseminated (weeks to months) Multiple EM; neuroborreliosis (painful radiculitis, facial palsy , lymphocytic meningitis; Bannwarth syndrome); Lyme carditis (atrioventricular block)

  • Late (months to years) Lyme arthritis (often the knee); acrodermatitis chronica atrophicans (ACA)
  • Diagnosis

Erythema migrans is a clinical diagnosis. Serology is often negative in early EM and is not needed . Patients should not wait for tests before treatment.

Borrelial lymphocytoma and ACA: serology helps. ACA almost always shows high IgG antibody levels , and biopsy supports the diagnosis.

Neuroborreliosis: CSF pleocytosis with intrathecal antibody production.

Serology cannot distinguish active from past infection. Testing ticks is not recommended.

Acrodermatitis Chronica Atrophicans

ACA typically affects older women . It begins with bluish-red swelling on the extensor surface of a limb (often the back of a hand, foot, or knee), which slowly becomes atrophic, thin, "cigarette-paper" skin with visible veins. Firm fibrous nodules can develop near joints, and there may be a peripheral neuropathy. It is usually caused by B. afzelii .

Treatment (European guidance)

Manifestation First-Line Alternatives Duration

Erythema migrans Doxycycline 100 mg twice daily or 200 mg once daily Amoxicillin 500–1,000 mg three times daily (children, pregnancy); azithromycin (5–7 days) or cefuroxime About 10–14 days (10 days of doxycycline is usually enough)

Borrelial lymphocytoma Doxycycline or amoxicillin As for EM About 14 days

Acrodermatitis chronica atrophicans Doxycycline or amoxicillin Ceftriaxone if neurological involvement About 21–28 days

Neuroborreliosis Doxycycline 200 mg daily or IV ceftriaxone — About 14 days

Doxycycline is avoided in pregnancy and, in many countries, in young children, although short courses are increasingly accepted in children.

Tick removal: remove promptly with fine tweezers or a tick card close to the skin. Routine antibiotic prophylaxis after a tick bite is not generally recommended in Europe.

Some patients have fatigue or pain after treatment. Prolonged antibiotic courses do not help.

European Rickettsioses and Other Tick-Borne Infections

Infection Organism and Vector Features Treatment

Mediterranean spotted fever Rickettsia conorii ; brown dog tick ( Rhipicephalus sanguineus ) Fever, headache, a black eschar ("tache noire") at the bite, and a maculopapular rash including palms and soles Doxycycline

TIBOLA / SENLAT R. slovaca ; Dermacentor ticks Scalp eschar with painful neck lymphadenopathy after a tick bite in cold months Doxycycline

Tick-borne encephalitis Flavivirus; Ixodes Two-phase illness with meningoencephalitis; no specific skin sign Vaccination for prevention

Tularaemia Francisella tularensis ; ticks, hares, rodents, water Ulceroglandular form: ulcer at inoculation with large regional lymph nodes Ciprofloxacin or doxycycline; gentamicin in severe cases

Bartonella Infections

Cat-scratch disease ( Bartonella henselae ): a papule or pustule at a cat scratch, followed after 1–3 weeks by tender regional lymphadenopathy. It is usually self-limiting; azithromycin shortens lymphadenopathy.

Bacillary angiomatosis ( B. henselae or B. quintana ): red vascular papules and nodules in severely immunosuppressed patients, especially with advanced HIV, which mimic Kaposi sarcoma. Warthin-Starry silver stain shows the bacteria. Treat with erythromycin or doxycycline.

Infections from Animals and Animal Products

Infection Source and Features Treatment

Erysipeloid ( Erysipelothrix rhusiopathiae ) Fish, meat, and poultry handlers; a painful, well-defined violaceous plaque on the hand or finger, spreading slowly Penicillin

Cutaneous anthrax ( Bacillus anthracis ) Contact with animal hides, wool, or contaminated heroin; a papule becoming a painless black eschar with marked surrounding oedema Ciprofloxacin or doxycycline; notify public health; do not debride

Pasteurella multocida Cat and dog bites ; rapid cellulitis within 24 hours Co-amoxiclav (also for prophylaxis of high-risk bites)

Mycobacterium marinum Fish tanks and swimming pools; granulomatous nodules, sometimes in a sporotrichoid line See the mycobacterial section

  • Orf and milker's nodule Sheep and goats; cattle See the poxvirus section
  • Travel-Related Infestations

Condition Cause Features Treatment

Cutaneous larva migrans Animal hookworm larvae (for example Ancylostoma braziliense ) from beaches and soil Itchy serpiginous tracks on the feet or buttocks, moving a few mm to cm a day Ivermectin single dose or albendazole for 3–7 days

Larva currens Strongyloides stercoralis autoinfection Fast-moving urticarial track around the buttocks and thighs; risk of hyperinfection with corticosteroids Ivermectin; screen before immunosuppression in at-risk patients

Tungiasis Sand flea Tunga penetrans Painful papule with a central black dot, usually on the toes Sterile extraction; tetanus cover

Furuncular myiasis Fly larvae (for example Dermatobia hominis ) Boil-like lesion with a central pore and a sensation of movement Occlude the pore, then extract the larva

Leishmaniasis Leishmania species See the parasitic infections section —